Medicines Australia working to minimize supply shortages

Medicines Australia and the Generic and Biosimilars Medicines Association (GBMA) have shared concerns about medicine shortages that are impacting patients in the country.

The Therapeutic Goods Administration (TGA) has listed 47 medicines that are experiencing critical shortages due to issues brought about by the COVID-19 pandemic, with many having limited availability. Attempting to deal with ongoing shortages has formed a significant part of recent strategic agreements between Medicines Australia and the government.

Elizabeth de Somer, chief executive of Medicines Australia, said: “The pandemic has highlighted the complexities and vulnerabilities in global medicine supply chains and has increased the focus on medicine shortages in Australia.”